Corbus Pharmaceuticals Holdings Inc —— 资产负债表 (NASDAQ:CRBP) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 102.29 M107.73 M66.31 M28.27 M155.88 M168.19 M 负债总额 57.02 M38.62 M33.32 M35.18 M13.45 M20.69 M 权益总额 45.27 M69.11 M32.99 M-6.9 M142.43 M147.5 M 负债及股东权益总额 102.29 M107.73 M66.31 M28.27 M155.88 M168.19 M 总债务 18.74 M18.73 M18.78 M15.91 M3.24 M— 净债务 -66.69 M-78.92 M-40.42 M-5 M-145.82 M—

新闻

How Much Upside is Left in Corbus Pharmaceuticals (CRBP)? Wall Street Analysts Think 318.33%

Corbus制药公司股价在肥胖药物安全数据表现良好后上涨

Corbus Pharmaceuticals stock rises after promising obesity drug safety data

Corbus reports positive phase 1 results for obesity drug CRB-913

Corbus to release phase 1a study results for obesity drug CRB-913

Corbus Pharmaceuticals: Data Update, Fundraising Do Not Diminish The Thesis

Corbus Pharmaceuticals: Downgrade To Hold Due To Narrow Focus Window (NASDAQ:CRBP)

Corbus制药公司股价在7500万美元公开发行后暴跌

Corbus Pharmaceuticals stock plunges after $75 million public offering

Roku, SPS Commerce, Newell Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Cooper-Standard Holdings (NYSE:CPS), Aptiv (NYSE:APTV)

Corbus定价7500万美元普通股公开发行

Corbus prices $75 million public offering of common stock